EMJ GOLD

Diversity and inclusion (D&I) has become a core focus for pharma, but how can it go one step further and cultivate a culture of belonging?

we look at how AI tools can boost traditional marketing campaigns’ productivity, improve targeting, and deliver significant business value.

In what ways can we hold each other accountable, not just for the number of women in leadership, but how women, and especially women of colour, are represented and supported throughout the hiring pipeline?

After years of tough negotiations, the UK has left the European Union. GOLD explores how pharmaceutical innovation has been affected as the UK works to replace EU resources and make use of its new-found regulatory freedom

The disruptor that is COVID-19 has turned everything upside down, including disease awareness campaigns. GOLD catches up with pharma marketing experts to see how they have adapted to their circumstances.

The pharmaceutical industry has long struggled with its reputation, but 2020 offered an opportunity for reform. How has their response to the crisis affected perceptions, or is misinformation still getting in the way?

While attention was channelled into COVID-19, patients awaiting other treatments were deprioritised. How can pharma ensure no patients are left behind?

Hear from two thought leaders who share their passion for health economics, their thoughts on non-traditional models, and how they predict drugs will be costed in the future.